---
title: "Would You Buy Generic AI?"
description: "DeepSeek V3 matches GPT-5.2 on most benchmarks. It costs 90% less. AI has its generic drug moment."
categories: ["AI","data","startups"]
keywords: ["Chinese AI","DeepSeek","OpenAI","Anthropic","AI pricing","AI commoditization","generic AI"]
date: 2026-03-02
lastmod: 2026-07-27
canonical_url: https://www.tomtunguz.com/white-label-ai/
author: "Tomasz Tunguz"
---


Kirkland ibuprofen is the same molecule as Advil. Same dosage, same FDA requirements, same therapeutic effect.[^1] It costs 80% less.

AI has its generic drug moment. DeepSeek V3 matches GPT-5.2 on most benchmarks.[^2] It costs 90% less. OpenAI & Anthropic generated $22 billion in 2025.[^3] Chinese AI labs generated $1.8 billion.[^4] The ratio : 12:1.

{{< email_image src="gszmbeayrmmzrlrhb7go" alt="AI Lab Revenue 2025 - US vs China" width="540" height="304" >}}

Pricing explains the gap. Chinese AI API prices collapsed 90% in 2024.[^5] US frontier models average $3.38 per million input tokens. Chinese models average $0.48.

| Company | Model | Input ($/1M tokens) | Output ($/1M tokens) |
|---------|-------|--------------------:|---------------------:|
| Anthropic | Claude Opus 4.6 | 5.00 | 25.00 |
| OpenAI | GPT-5.2 | 1.75 | 14.00 |
| Zhipu | GLM-5 | 1.00 | 3.20 |
| Minimax | M2.5 | 0.30 | 1.20 |
| DeepSeek | V3 | 0.14 | 0.28 |

OpenAI processes roughly 8.6 trillion tokens per day.[^6] Chinese labs likely match or exceed this volume. The 12:1 revenue gap isn't usage. It's price.

Three forces drive Chinese prices down.

First, distillation commoditizes capability. Anthropic accused DeepSeek, Minimax & Moonshot AI of conducting "industrial-scale campaigns" to extract knowledge from Claude.[^7] OpenAI made similar accusations to Congress.[^8]

Second, hyperscalers subsidize AI to win cloud customers. Alibaba Cloud cut LLM pricing by up to 97%.[^9] Baidu, ByteDance & Tencent spent $1.1B on AI subsidies during Chinese New Year 2026 alone.[^10]

Third, DeepSeek set the floor. They trained V3 for $6 million versus OpenAI's $100 million+ for GPT-4,[^11] price at $0.14 per million input tokens & hit $220 million ARR with 122 employees.

In the US, Chinese models also price at a discount. Together AI charges $1.25 per million input tokens for DeepSeek V3.[^12] DeepInfra offers $0.21 per million.[^13] DeepSeek's own API charges $0.14 - 12x less than GPT-5.2.[^14]

{{< email_image src="wlpt04ac7clpm7tb8yut" alt="DeepSeek V3 Pricing by Provider vs OpenAI GPT-5.2" width="540" height="304" >}}

Pharma companies spend billions developing a molecule, then enjoy 20 years of patent protection to recoup R&D costs before generics flood the market. AI follows the same pattern - massive R&D costs upfront, then commoditization. But the timeline is compressed.

In pharma, the generic window opens after two decades. In AI, it opens in weeks. DeepSeek V3 costs $0.14 per million tokens. GPT-5.2 costs $1.75. Same capability. Different label. The 90% discount isn't coming. It's here.

The question : how to protect an asset that takes hundreds of millions to develop when it can be copied in a month?

---

**Sources**

[^1]: [Generic vs Brand Name Ibuprofen - CBS News](https://www.cbsnews.com/news/generic-and-store-brands-vs-brand-names/)
[^2]: [DeepSeek-V3 Technical Report - arXiv](https://arxiv.org/abs/2412.19437)
[^3]: [OpenAI Revenue - The Information](https://www.theinformation.com/briefings/openai-track-top-13-billion-revenue), [Anthropic Revenue - Bloomberg](https://www.bloomberg.com/news/articles/2026-01-21/anthropic-s-revenue-run-rate-tops-9-billion-as-vcs-pile-in)
[^4]: Chinese AI lab revenues (trailing 12 months as of mid-2025) : [4Paradigm $834M - KrASIA](https://kr-asia.com/4paradigm-eyes-agi-with-30-revenue-growth-new-compute-stack), [SenseTime $610M - Yahoo Finance](https://finance.yahoo.com/news/sensetimes-ai-growth-surges-china-093000158.html), [DeepSeek $220M - Business of Apps](https://www.businessofapps.com/data/deepseek-statistics/), [Minimax $79M, Zhipu $70M - industry estimates]
[^5]: [China AI Price War - South China Morning Post](https://www.scmp.com/tech/big-tech/article/3264909/new-ai-battle-adopts-old-price-war-strategy-chinese-tech-giants-keep-start-ups-bay-behind-great)
[^6]: [OpenAI Token Volume - PYMNTS](https://www.pymnts.com/artificial-intelligence-2/2025/openai-bests-google-in-race-for-consumer-ai-token-consumption/)
[^7]: [Anthropic Distillation Claims - CNBC](https://www.cnbc.com/2026/02/24/anthropic-openai-china-firms-distillation-deepseek.html)
[^8]: [OpenAI DeepSeek Memo - Bloomberg](https://www.bloomberg.com/news/articles/2026-02-12/openai-accuses-deepseek-of-distilling-us-models-to-gain-an-edge)
[^9]: [Alibaba 97% Price Cuts - SiliconAngle](https://siliconangle.com/2025/01/01/alibaba-cloud-announces-aggressive-llm-price-cuts-bid-dominate-chinas-ai-market/)
[^10]: [Chinese New Year AI Spending - Morgan Stanley](https://www.asiatechlens.com/p/the-chinese-new-year-ai-gateway-war-tencent-bytedance-baidu-alibaba-cny)
[^11]: [GPT-4 Training Cost - TechRadar](https://www.techradar.com/pro/openai-spent-usd80m-to-usd100m-training-gpt-4-chinese-firm-claims-it-trained-its-rival-ai-model-for-usd3-million-using-just-2-000-gpus)
[^12]: [Together AI Pricing](https://www.together.ai/pricing)
[^13]: [DeepInfra Pricing - Artificial Analysis](https://artificialanalysis.ai/models/deepseek-v3-1/providers)
[^14]: [DeepSeek Official Pricing](https://api-docs.deepseek.com/quick_start/pricing)